Skip to main content

Per fare trading negli USA, vai su polymarket.us

icon for Heidi Overton confermata Commissario FDA da…?
Politica·Trump

Heidi Overton confermata Commissario FDA da…?

icon for Heidi Overton confermata Commissario FDA da…?
Politica·Trump

Heidi Overton confermata Commissario FDA da…?

$19,602 Vol.

30 set 2026
Polymarket

$19,602 Vol.

Polymarket

30 settembre

$11,044 Vol.

10%

31 ottobre

$4,762 Vol.

33%

30 novembre

$1,097 Vol.

30%

31 dicembre

$2,700 Vol.

54%

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.**Heidi Overton’s Senate confirmation as FDA commissioner hinges on navigating Republican-led committee scrutiny and building sufficient support in a narrowly divided chamber.** Nominated by President Trump in mid-August 2026 to replace Marty Makary, who resigned in May, Overton currently serves as deputy director of the White House Domestic Policy Council and has shaped administration health priorities including vaccine scheduling and MAHA initiatives. Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy has voiced strong concerns over her managerial experience and role in recent vaccine policy actions, signaling potential hurdles for a committee vote. Democrats have raised additional opposition, while the agency continues under Acting Commissioner Kyle Diamantas amid ongoing leadership transitions and staffing challenges. Confirmation timelines, committee hearings, and any shifts in key Republican support remain the central variables for market resolution.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Volume
$19,602
Data di fine
1 gen 2027
Mercato aperto
Aug 20, 2026, 5:43 PM ET

Risolutore

0x65070BE91...
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.**Heidi Overton’s Senate confirmation as FDA commissioner hinges on navigating Republican-led committee scrutiny and building sufficient support in a narrowly divided chamber.** Nominated by President Trump in mid-August 2026 to replace Marty Makary, who resigned in May, Overton currently serves as deputy director of the White House Domestic Policy Council and has shaped administration health priorities including vaccine scheduling and MAHA initiatives. Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy has voiced strong concerns over her managerial experience and role in recent vaccine policy actions, signaling potential hurdles for a committee vote. Democrats have raised additional opposition, while the agency continues under Acting Commissioner Kyle Diamantas amid ongoing leadership transitions and staffing challenges. Confirmation timelines, committee hearings, and any shifts in key Republican support remain the central variables for market resolution.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Volume
$19,602
Data di fine
1 gen 2027
Mercato aperto
Aug 20, 2026, 5:43 PM ET

Risolutore

0x65070BE91...

Correlati

icon for Hung Cao sarà confermato come Segretario della Marina entro il 31 dicembre?

Hung Cao sarà confermato come Segretario della Marina entro il 31 dicembre?

61%
Sì
icon for Von der Leyen fuori come presidente della Commissione Europea nel 2026?

Von der Leyen fuori come presidente della Commissione Europea nel 2026?

7%
Sì
icon for Alexandria Ocasio-Cortez vincerà la nomina presidenziale democratica del 2028?

Alexandria Ocasio-Cortez vincerà la nomina presidenziale democratica del 2028?

19%
Sì

Fai attenzione ai link esterni.

Domande frequenti

"Heidi Overton confermata Commissario FDA da…?" è un mercato predittivo su Polymarket con 4 possibili esiti dove i trader comprano e vendono azioni in base a ciò che credono accadrà. L'esito attualmente in testa è "31 dicembre" a 54%, seguito da "31 ottobre" a 33%. I prezzi riflettono probabilità aggregate in tempo reale. Ad esempio, un'azione quotata a 54¢ implica che il mercato assegna collettivamente una probabilità di 54% a quell'esito. Queste quote cambiano continuamente man mano che i trader reagiscono a nuovi sviluppi e informazioni. Le azioni nell'esito corretto possono essere riscattate per $1 ciascuna alla risoluzione del mercato.

Ad oggi, "Heidi Overton confermata Commissario FDA da…?" ha generato $19.6K in volume totale di trading dal lancio del mercato il Aug 20, 2026. Questo livello di attività di trading riflette un forte coinvolgimento della comunità Polymarket e contribuisce a garantire che le quote attuali siano informate da un ampio pool di partecipanti al mercato. Puoi seguire i movimenti di prezzo in tempo reale e fare trading su qualsiasi esito direttamente su questa pagina.

Per fare trading su "Heidi Overton confermata Commissario FDA da…?", esplora i 4 esiti disponibili elencati in questa pagina. Ogni esito mostra un prezzo corrente che rappresenta la probabilità implicita del mercato. Per prendere una posizione, seleziona l'esito che ritieni più probabile, scegli "Sì" per fare trading a suo favore o "No" per fare trading contro di esso, inserisci il tuo importo e clicca "Trading". Se il tuo esito scelto è corretto alla risoluzione del mercato, le tue azioni "Sì" pagano $1 ciascuna. Se è errato, pagano $0. Puoi anche vendere le tue azioni in qualsiasi momento prima della risoluzione se vuoi consolidare un profitto o limitare una perdita.

L'attuale favorito per "Heidi Overton confermata Commissario FDA da…?" è "31 dicembre" a 54%, il che significa che il mercato assegna una probabilità di 54% a quell'esito. L'esito successivo più vicino è "31 ottobre" a 33%. Queste quote si aggiornano in tempo reale man mano che i trader comprano e vendono azioni, quindi riflettono l'ultima visione collettiva di ciò che è più probabile che accada. Controlla frequentemente o aggiungi questa pagina ai preferiti per seguire come cambiano le quote man mano che emergono nuove informazioni.

Le regole di risoluzione per "Heidi Overton confermata Commissario FDA da…?" definiscono esattamente cosa deve accadere affinché ogni esito venga dichiarato vincitore — comprese le fonti di dati ufficiali utilizzate per determinare il risultato. Puoi consultare i criteri completi di risoluzione nella sezione "Regole" di questa pagina sopra i commenti. Ti consigliamo di leggere attentamente le regole prima di fare trading, poiché specificano le condizioni precise, i casi limite e le fonti che regolano come viene risolto questo mercato.